Skip to Content

Herborium Group Inc HBRM

Morningstar Rating
$0.00 0.00 (50.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HBRM is trading at a 41% premium.
Price
$0.00
Fair Value
$6.56
Uncertainty
Extreme
1-Star Price
$9.46
5-Star Price
$1.43
Economic Moat
Vmpc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HBRM is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$545,971.44
Volume/Avg
4.1 Mil / 3.1 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Herborium Group Inc provides natural, & complementary healthcare-related products to consumers & healthcare professionals seeking alternative answers to the management of healthcare issues not currently met by standard Western medicine. Its focus is on developing, licensing, & marketing proprietary, botanical-based medicinal products, targeting unmet medical needs. Its products are botanical supplements comprised of herbal formulations, referred as botanical therapeutics. Substantially all of the company's revenue has been derived from the sale of AcnEase through its corporate website. The Company responds to both consumer & healthcare professionals demand for safe, efficacious, all-natural medicinal options for the treatment and prevention of selected diseases & health concerns.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
1

Valuation

Metric
HBRM
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
HBRM
Quick Ratio
0.00
Current Ratio
0.03
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
HBRM
Return on Assets (Normalized)
−566.94%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AMhqqfmjpZgxz$79.4 Bil
MKKGY
Merck KGaA ADRHngrzjvhhpLvjkbnw$79.0 Bil
HLN
Haleon PLC ADRDwfzhgkJxnrx$38.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRLpztlnxhbLzl$17.7 Bil
VTRS
Viatris IncRslvzymcKdjm$13.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRDxsdcpqYqjvy$11.6 Bil
CTLT
Catalent IncLyptrhjsNxysl$10.0 Bil
CURLF
Curaleaf Holdings IncKymkzfqgRwp$4.2 Bil
PRGO
Perrigo Co PLCVrgnfvkvHffhp$4.1 Bil
PBH
Prestige Consumer Healthcare IncFhzmwwkfQgmhrs$3.2 Bil

Sponsor Center